Back to search
Castleman's Disease (CD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Castleman's Disease (CD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Castleman's Disease (CD) trials you may qualify forThe research study is being done to look at the effects of ruxolitinib in adults with idiopathic Multicentric Castleman Disease (iMCD) that has not gotten bette…
The purpose of this study is to collect clinical, laboratory, and patient survey data from patients with Castleman disease to improve understanding, diagnosis,…
The purpose of this study is to use agnostic genomic evaluation using whole exome sequencing (WES) of a variety of rare hematologic diseases grouped under rare…
The purpose of this study is to understand the impact of sirolimus on idiopathic multicentric Castleman disease.
Castleman disease, a rare lymphoproliferative disorder, is characterized by inflammatory cytokine production and multiple organ system dysfunction. In this stud…